The European Commission has kindly offered app developers who are DHACA members a free pass for their event in eHealth Week in Riga beginning May 11th. There is urgency though – they need names by close of play on Monday 4th May (which is not a Bank Holiday in Belgium although it is here). Please let me know (email@example.com) as soon as possible if you want a pass so I can send the list on. They do stress that obviously the EC will not pay flight and hotel costs – however apparently both remain low at present. Their reason
The recent item in mobihealthnews draws attention to the article in the Journal of the American Medical Association about how people can tell which medical apps are effective, and the counterpoint discussion in the British Medical Journal on whether apps can help healthy people. Though both are a good read, neither will come as any great surprise to DHACA members who have been following the debate on medical apps, and the work that has been taking place within DHACA on these very topics under the auspices of the mHealth apps Special Interest Group (SIG).
Charles Lowe, DHACA’s Managing Director, was invited to this event on 26th March as the editor of DHACA’s comprehensive EC mHealth Green Paper response. This is his summary of the event and the follow-on actions from it The event was very well attended – the EC’s engagement with mHealth is clearly an area of considerable interest to commerce as most of the big firms working in this area attended the event last week. Particular points of relevance to DHACA members were:.
- Wearables and apps are increasingly seen as providing a single health-related service, together, yet currently are
“How can you start doing anything with healthcare apps when there are over 40,000 of them out there?” I was asked at least ten times at EHI Live this week. My answer was that there are only some 0.5% of those that are what I call “medical apps”, that really deserve attention, now. These are apps that for example might either meet, or be close to meeting, the definition of a medical device in the Medical Devices Directive 93/42EC: that have the power to do great harm if in error, and great good if properly constructed and maintained. Or